sofosbuvir

Medicine Nobel for Hep C Should Force Us to Think About Patents, Patients, Profits

DCGI Rejects Mylan’s Request to Waive Phase 3 Trials for COVID-19 Drug

A Brief History of Pharmaceutical Profiteering

In India, Stakeholders Drive Down Drug Prices for the Benefit of All

Credit: rico_gustav/Flickr, CC BY 2.0 (patent)

All You Need to Know: September’s Crucial Verdict on the Sofosbuvir Patent Saga

Just some pills. Credit: naturegeak/Flickr, CC BY 2.0

Patent Profits and the Global Burden of Curing Hep-C